We have investigated whether the skin-homing T lymphocytes identified by the cutaneous lymphocyte antigen (CLA) are increased in the synovial membrane of patients with psoriatic arthritis. Twenty-six synovial samples (13 psoriatic arthritis, seven rheumatoid arthritis, six osteoarthritis) were obtained from involved knees. Lesional skin biopsies were taken from nine of the patients with psoriatic arthritis and six patients with psoriasis alone. All samples were single-and dual-stained for CLA and CD3 (to identify T lymphocytes) using HECA-452 (anti-CLA) and anti-CD3 monoclonal antibodies. E-selectin expression was also determined. The percentage of dual-stained lymphocytes was significantly greater in psoriatic skin than in synovium (P Q 0.001) and similar between psoriatic and rheumatoid synovium. There was no significant difference in the percentages of CLA-positive cells in psoriatic skin in patients with psoriatic arthritis compared with psoriasis alone. The intensity of endothelial E-selectin expression was significantly greater in skin psoriasis than in synovium (P Q 2 × 10 −5 ), and rheumatoid synovium had significantly greater expression than psoriatic synovium (P Q 0.05). However, there was no significant correlation between E-selectin expression and the percentages of CLA-positive lymphocytes. This study provides further evidence that the CLA antigen is enriched on skin-homing lymphocytes. Conversely, the link between skin and joint inflammation in psoriatic arthritis does not seem to be explained by increased trafficking of CLA T cells to psoriatic synovium.
P is an inflammatory and proliferative skin disorder with a prevalence of 1.5-3%. Approximately 20% of patients with psoriasis develop a characteristic form of arthritis that has several patterns [1] [2] [3] [4] [5] . Some individuals present with joint symptoms first, but in the majority, skin psoriasis presents first. About one-third of patients have simultaneous exacerbations of their skin and joint disease [6] , and there is a topographic relationship between nail and distal interphalangeal joint disease [4, 7] . Gerber and Espinoza [8] postulated that 'noxious substances' may traffic between the sites, linking their involvement. Although the inflammatory processes which link skin, nail and joint disease remain elusive, an immune-mediated pathology is implicated.
Immunopathogenic mechanisms involving T lymphocytes in psoriasis and arthritis appear similar. Both the skin and synovium are infiltrated with activated T lymphocytes [9, 10] , with a preponderance of CD4RO+ cells, known to migrate preferentially to peripheral tissues [10] . There are known associations with major histocompatibility haplotypes [11, 12] . Both psoriasis and arthritis increase in severity with the depletion of T-helper lymphocytes secondary to HIV infection [13, 14] , and both improve in response to immunotherapy such as cyclosporin A.
The skin is a functionally unique immune site with apparently a specific homing mechanism for T cells. The cutaneous lymphocyte antigen (CLA), defined by the monoclonal antibody HECA-452, identifies a population of skin-homing memory T cells [15] . The receptor for CLA on dermal endothelium is the inducible cell adhesion molecule E-selectin [16] , a protein which also acts to tether neutrophils during their initial rolling interaction with the blood vessel wall at the onset of an inflammatory response [17, 18] . It has been proposed that E-selectin on venules at sites of acute inflammation supports neutrophil recruitment, whereas in sites of chronic inflammation in the skin it mediates accumulation of CLA-positive T cells [16] .
The principal aim of the current study was to determine whether skin and joint disease in psoriatic arthritis may be linked through the inappropriate expression of CLA molecules, E-selectin or both. We have therefore investigated the percentages and distribution of skin-homing (CLA-positive) T lymphocytes and their counter-receptor E-selectin in the skin, synovium and peripheral blood of patients with psoriatic arthritis and appropriate controls.
MATERIALS AND METHODS
The study was approved by the Bath and South West Ethical Committee. Written consent was obtained for biopsies.
Patients
Thirteen patients with psoriatic arthritis and synovitis of a knee were recruited from a psoriatic arthritis clinic. Clinical information including the age, sex, duration of psoriasis and arthritis, subgroup of joint disease, presence of erosions, degree of knee synovitis, skin severity, periodicity of skin and joint disease, and the presence of nail disease was recorded. All patients had active psoriasis and were seronegative for rheumatoid factor. Controls included samples from seven patients with seropositive rheumatoid arthritis (RA) defined by the American College of Rheumatology [19] , six patients with osteoarthritis and six patients with psoriasis alone. No patient or control had received an intra-articular steroid injection within 3 months of obtaining synovial samples.
Immunohistochemistry
Sample collection.
(1) Synovium: Biopsies were taken from knee joints by a standard blind needle biopsy technique using a Polley's needle after local anaesthesia. At least six samples of synovial membrane were obtained from different regions of the suprapatellar pouch. Paraffin sections were obtained for descriptive histology. Samples from two of the patients with RA and three of the six patients with osteoarthritis were obtained at the time of arthroscopy or joint replacement.
(2) Skin: Elliptical skin samples were obtained from nine patients with psoriatic arthritis, eight of whom had concurrent synovial biopsies, and six patients with psoriasis alone, recruited from a dermatology clinic. A musculoskeletal history and joint examination were performed to confirm the absence of arthritis in the latter patients. Biopsies were taken from lesional edges of the most active accessible plaques. In one patient, the skin biopsy was taken from a plaque directly on the involved knee.
Further control tissue included three samples of normal skin from healthy volunteers, one sample of lesional skin from a patient with severe eczema, and a sample of normal tonsil.
Preparation of sections. Tissue sections of skin and synovium were mounted on cork with 5% polyvinyl alcohol (PVA), snap frozen in liquid nitrogen and stored at −70°C. The cork was mounted onto a metal chuck with PVA and 8 mm sections were cut on a cryostat at −25°C. Sections were mounted serially on 4-well glass slides, air-dried for 1 h and fixed in acetone at room temperature for 10 min, wrapped in tin-foil and stored at −20°C prior to use. Histology was checked every 10 sections using a rapid staining technique (Diffquick). Synovial specimens without clearly defined synovial lining cells, and skin specimens without identifiable epidermis and dermis, were discarded.
Materials. The antibodies and other reagents used are listed in Table I . The monoclonal antibody HECA-452 was provided by Dr Louis Picker, University of Texas, USA.
Single-staining for CD3 and CLA. CD3 populations were quantified using anti-CD3 supernatant (undiluted) or control mouse IgG (dilution 1 in 500) and alkaline phosphatase/monoclonal anti-alkaline phosphatase (APAAP) complexes using a standard method described by the manufacturer (Dakopatts).
Sections were stained for CLA using HECA-452 (rat IgM) and a standard biotin/streptavidin-alkaline phosphatase technique: (1) blocking step for 20 min with human AB serum in 5% solution with Tris-buffered saline (TBS); (2) 1 h incubation with HECA-452 monoclonal antibody (rat IgM) at 1/30 dilution or control rat IgM (1/100 dilution); (3) 30 min incubation with biotinylated species-specific anti-rat immunoglobulins at 1/50 dilution; (4) 30 min incubation with streptavidin-alkaline phosphatase at 1/50 dilution; (5) Fast red/substrate for 15-20 min at room temperature. All reagents were diluted in TBS and 100 ml of diluent used for each section. Each stage was followed by washing for 1-2 min in TBS. Finally, the sections were lightly counterstained with haematoxylin and mounted.
The HECA-452 monoclonal antibody is not T-cell specific, but also identifies related E-selectin ligands on high endothelial venules (HEVs), neutrophils and monocytes. Therefore, double fluorescence staining was used to estimate the percentage of CLA-positive T lymphocytes. Fluorescence double-staining. Sections were doublestained for CLA and CD3 using HECA-452 and anti-CD3 supernatant and fluorescein isothiocyanate (FITC) and tetramethylrhodamine isothiocyanate (TRITC) conjugates, respectively, and appropriate non-reactive control monoclonal antibodies. Each serial 4-well slide had a control section, single-stained sections for CLA and CD3, and a double-stained section. The incubation steps for double-staining were: (1) 20 min blocking step with human AB serum in 5% solution with phosphate-buffered saline (PBS); (2) 45 min incubations with anti-CD3 supernatant (undiluted) and goat TRITC anti-mouse IgG (1 in 50); (3) 20 min blocking step with 5% normal mouse serum (NMS); (4) HECA-452 monoclonal antibody (1/30 dilution); (5) 45 min incubation with rabbit biotinylated species-specific anti-rat immunoglobulins (1/50); (6) FITC-streptavidin (1/50). All antibodies were diluted in PBS and each stage was followed by washing for 1-2 min with PBS. The sections were mounted using 1,4-diazabicyclo(2,2,2)octane (DABCO) as an interface.
Three psoriatic synovial sections were similarly double-stained for macrophages using anti-CD68 instead of anti-CD3.
Sections were stained in duplicate or triplicate, blinded to the diagnosis and scored by two investigators (SJ and JD). The numbers of single-and double-stained T lymphocytes were assessed in the dermis of the skin and sublining layer of the synovium. Sequential fields were studied using an eyepiece orientated along the dermo-epidermal junction or synovial lining layer. A section was only scored if the singly stained section was of equivalent intensity to the dual-stained section. Inter-observer variability was within 10%.
Determination and quantitation of E-selectin expression. The anti-E-selectin monoclonal antibody was used followed by the APAAP complex, according to the protocol described by the manufacturers (Dakopatts), followed by haematoxylin counterstaining. Endothelial morphology was confirmed in longitudinally cut vessels by the endothelial cell marker anti-CD34. Anti-E selectin was used at a dilution of 1/200, anti-CD34 and APAAP at 1/50. Vessels in the dermis of the skin and synovial sublining were scored in sequential fields. The number of vessels, the proportion of E-selectin-positive vessels and the intensity of staining were determined on an arbitrary scale as follows: 0 = no staining detected; 1 = minimal staining; 2 = moderate staining; 3 = strong staining. The mean intensity was computed for each section. The density of the surrounding inflammatory infiltrate was also determined using the following scale: 0 = no inflammatory infiltrate; 1 = small inflammatory infiltrate; 2 = moderate inflammatory infiltrate; 3 = dense inflammatory infiltrate.
Flow cytometry
Sample collection. Ten millilitres of venous blood were taken from 12 patients with psoriatic arthritis, six with RA and six normal controls. All the psoriatic arthritis and RA patients had clinical evidence of active synovitis. Three of the psoriatic arthritis patients were included in the immunohistological study (Table II, 
patients 3, 4 and 7).
Materials. The reagents used are listed in Table I . The FITC-conjugated HECA-452 monoclonal antibody and a control FITC-conjugated rat IgM with unspecified reactivity were donated by Dr Picker and used undiluted.
Methods. Mononuclear cells (MNC) were separated from 10 ml of heparinized whole blood using a standard lymphoprep gradient. Briefly, 10 ml of heparinized blood were taken from each patient. The separated MNCs were washed with medium, counted and resuspended in RPMI and 10% fetal calf serum, and pre-incubated with 50 ml of undiluted normal human serum. A total of 5 × 10 5 cells were used per test. The following reagents were added: (1) anti-CD3, (2) phycoerythrin (PE)-conjugated anti-mouse immunoglobulins (1/50) and (3) FITC-conjugated HECA-452 monoclonal antibody (undiluted) with appropriate controls minus one or more reagents. After 30 min incubation, the cells were resuspended in PBS containing 1% paraformaldehyde.
Flow cytometry was performed using a Becton-Dickinson FACStar Plus with an air-cooled argon laser and Consort 32 computer. Gating was performed by setting the threshold with reference to the relevant negative control. The percentages of CLA-positive circulating T lymphocytes in the peripheral blood of patients with psoriatic arthritis, RA and normal controls were determined.
Data analysis
Data were analysed using a Hewlett Packard personal computer with software packages including Microsoft EXCEL and STATMOST. Normality testing was performed prior to analysis. Duncan's test for multiple comparisons was used for the various patient groups. The Mann-Whitney U-test was used to compare all the psoriatic skin versus the synovial samples. The Wilcoxon signed rank test was used for paired psoriatic skin and synovial data. Spearman's rank coefficient was used for correlation analysis.
RESULTS

Clinical characteristics
The patients represented a spectrum of disease severity for both joint and skin disease (Table II) . There were six females and seven males, mean age 44 (range 20-62 yr) and mean duration of arthritis 15 yr (range 6-27) and psoriasis 18 yr (range 0-36). One patient (patient 13) had trivial psoriasis only that at the time of synovial biopsy did not reach the criteria for a PASI score. The immunohistological data were assessed in relation to clinical parameters.
Immunohistology
T-lymphocyte populations. The distribution of T lymphocytes in each sample was quantified prior to double-staining (Table III) . Eight synovial samples (six osteoarthritis, two psoriatic arthritis) did not have sufficient lymphocytic infiltration to determine accurately the percentages of CLA-positive T cells. The two psoriatic arthritis patients had only mild synovitis at the time of biopsy. For the six osteoarthritis patients, only isolated lymphocytes were present, with an occasional double-stained cell. Apart from the osteoarthritis group, the mean numbers of T cells per field (T-cell density) were similar in the other four patient groups. There was a weak negative correlation between the T-cell density in synovium and the duration of arthritis, but this was not significant. There was also a weak positive correlation between the degree of synovitis clinically in psoriatic arthritis and the T-cell density, but this was not statistically significant.
Immunohistological distribution of the CLA antigen.
The CLA antigen was present on many cell types within the synovium, including T cells, vascular endothelium, neutrophils and macrophages. Its presence on macrophages was also confirmed by doublelabelling with an anti-CD68 monoclonal antibody. In the skin, CLA-positive lymphocytes were observed in all lymphocytic areas, both in perivascular lymphoid aggregates around superficial dermal vessels, immediately below the stratum basale and in the more diffuse cellular infiltrate. Other skin cell types also stained for also significantly greater in skin than synovium (P Q 0.02). In one paired sample of psoriatic skin and synovium (patient 8), the percentage expression was 48.5 and 34%, respectively.
There were no significant differences between the percentages of double-stained lymphocytes in psoriatic arthritis synovium compared with RA synovium. In skin psoriasis, there were no significant differences in the percentages of CLA-positive lymphocytes in patients who had arthritis compared with those with psoriasis alone. The percentages in the three samples of normal skin and from one sample of eczematous skin were similar (all 60%), but much less in tonsil (2.5%).
There were no significant associations between any clinical parameter and the percentages of doublestained lymphocytes in synovial tissue. There were no significant associations between the degree of synovitis clinically and the percentage of double-stained lymphocytes. In particular, there were no significant differences between the percentages of double-stained lymphocytes in the four patients who had coincident exacerbations of their skin and joint disease, and those in whom there was no apparent temporal association. The patient with the greatest percentage of doublestained lymphocytes in synovium (34%) did have simultaneous exacerbations of his skin and joint disease.
E-selectin expression. The mean number of blood vessels per field, the percentage of positively stained vessels, the E-selectin intensity and the density of the perivascular infiltrate are shown in Table IV The results for the disease group comparisons for the intensity of E-selectin expression were as follows: (a) E-selectin expression was significantly greater in skin than synovium (P Q 2 × 10 −6 ) and (b) in skin psoriasis compared with psoriatic synovium (P Q 2 × 10 −5 ); (c) E-selectin expression was significantly greater in RA synovium compared with psoriatic arthritis synovium (P Q 0.05); (d) in paired skin and synovial samples from patients with psoriatic arthritis, E-selectin expression was significantly greater in skin than synovium (P Q 0.018); (e) there was no significant difference in E-selectin expression in the skin of patients with arthritis compared with those without arthritis. When the numbers of positive vessels were used instead of E-selectin intensity, the results of these comparisons were similar. In 3/10 psoriatic arthritis synovial samples and 1/7 RA synovial samples, no E-selectin expression was seen. Minute quantities only of E-selectin were detected in osteoarthritis synovial membrane. In skin, E-selectin was expressed in all HECA-452 including macrophages, polymorphonuclear leucocytes, vascular endothelial cells and Langerhans cells.
CLA/CD3 double-staining. The percentages of CLA/CD3 double-stained lymphocytes in patient groups and control tissue are shown in Table III and Fig. 1 . Representative results of fluorescence doublestaining of CD3 and CLA for psoriatic skin and synovium are shown in Fig. 2a-d . There was a significant correlation between the density of the inflammatory infiltrate and the percentages of CLApositive T cells (P Q 0.05).
The following comparisons between disease groups were made: (a) all skin (N = 19) and all synovial samples (N = 18); (b) psoriasis (N = 15) and psoriatic arthritis synovium (N = 11); (c) psoriatic arthritis synovium (N = 9) and RA synovium (N = 7); (d) paired psoriatic arthritis synovial membrane and skin samples (N = 7); (e) psoriasis in patients with arthritis (N = 8) and those without arthritis (N = 6).
The percentages of lymphocytes double-stained for CLA and CD3 were significantly greater in (a) skin than synovium (P Q 10 −6 ) and (b) psoriasis than psoriatic arthritis synovium (P = 0.01). For paired skin and synovial samples from psoriatic arthritis patients, the percentages of double-stained lymphocytes were samples throughout the dermal vessels, including the deep dermal vasculature, and was present in all samples. E-selectin expression in skin and synovium is shown in Fig. 3 .
The numbers of vessels per field were significantly greater in synovium than all the skin samples, including the three samples of eczema and normal skin (P Q 0.03), and the difference remained significant Table III. when only psoriatic skin was analysed (P Q 0.04). However, there were no significant differences between the numbers of vessels per field between any of the remaining disease groups. There were no significant differences in the density of the perivascular infiltrates between the patient groups. For psoriatic arthritis synovium, there was a significant correlation between E-selectin expression and the density of the inflammatory infiltrate (P Q 0.005). For all the disease groups combined, there was a weak positive correlation between E-selectin expression and the density of the inflammatory infiltrate, but this was not significant. There were no significant correlations between E-selectin intensity and any clinical parameter or the percentages of CLApositive T cells.
CLA-positive T cells in peripheral blood.
Flow cytometry results for T lymphocytes double-stained for CD3 and CLA are shown in Fig. 4 . Patients with RA had slightly greater percentages of double-stained cells (median 4.8, range 2.6-8.4%) than those with psoriatic arthritis (median 2.9, range 1.4-5.8%) and four normal control patients (median 2.0, range 1.1-5.7). The differences between the disease and normal control groups were not significant.
DISCUSSION
Patients with psoriatic arthritis provide a unique opportunity for studying tissue-specific homing mechanisms that contribute to chronic inflammation. We have obtained paired samples of chronically inflamed skin and synovium from such patients, spanning all the patterns and severities of peripheral joint disease with the common features of knee synovitis and active skin disease. Our major finding is that there is a significantly greater percentage of CLA-positive lymphocytes in psoriatic skin compared with synovium in psoriatic arthritis, and that this difference is independent of the clinical characteristics. The data confirm previous evidence that the CLA molecule is enriched only on skin-homing T lymphocytes [15] and are similar to the results reported in another recent study of psoriatic E-selectin is upregulated on the vascular endothelium of inflammatory skin lesions [22] as well as other inflammatory sites [17] . The increased intensity of its expression in psoriatic skin compared with synovium found in the present study is similar to that previously reported by some [23] , but not others [20] . Although the increased expression of E-selectin in skin may have bearing on the greater expression of CLA on lymphocytes in skin, there was no significant correlation between E-selectin expression and the percentage of CLA-positive lymphocytes. E-selectin also binds neutrophils via the sialyl Lewis X moiety, so its expression could reflect neutrophil diapedesis prominent in psoriatic skin, but not synovium. The reduction in mean vascular E-selectin intensity in psoriatic arthritis compared with RA was also similar to that found previously [24] . We have also studied E-selectin expression in osteoarthritis and found small quantities, similar to that found in the normal synovium of amputees [25] .
The CLA antigen is not specific to psoriasis, but occurs in high percentage in normal and all inflammatory skin conditions, as we have found by studying normal skin and eczema. The remarkable similarity in the percentages of CLA-positive lymphocytes in all our patients also suggests that the molecule is not specific to psoriasis, but is globally present on the majority of T lymphocytes in all skin, independent of the lymphocyte density. CLA is not present on virgin T cells, but is upregulated on a subset of T cells undergoing the virgin to memory transition in secondary lymphoid tissues [26] . Upregulation of CLA occurs in a highly regulated tissue-selective manner. For example, CLA is upregulated on over half of the T cells undergoing the virgin to memory transition in skin-associated peripheral lymph nodes, but on fewer than 10% of transitional T cells in the mucosa of small bowel. In addition, CLA expression seems to be further upregulated when memory-effector T cells are reactivated in skin, indicating that the local microenvironment at the time of T-cell activation acts to influence the homing receptor repertoire of the resultant memory-effector cells.
In conclusion, our study supports the hypothesis that the CLA population of lymphocytes is essentially specific to skin, even when skin and an extracutaneous site of inflammation occur simultaneously in the same patient, as in psoriatic arthritis. Therefore, there is no evidence to suggest that skin psoriasis and arthritis are linked through a common mechanism involving CLA T-lymphocyte interactions with E-selectin. It remains possible that skin and joint disease in psoriatic arthritis could be linked through an undiscovered adhesion receptor for a particular T-lymphocyte subset, or by a common T-cell antigen. The topographic association of nail disease and distal interphalangeal joint disease still requires explanation, and examination of the distal interphalangeal joint and nailbed tissue itself may be the only way of determining related immunopathology. As skin disease usually precedes joint disease, knowledge of genetic susceptibility factors and arthritis [20] . Differential expression of the CLA antigen represents the single most prominent difference between the T-lymphocyte infiltrate in psoriatic skin and synovium. Furthermore, there was no significant difference in the numbers of CLA-positive T lymphocytes in peripheral blood between psoriatic arthritis, RA and normal healthy control patients. Therefore, there does not appear to be any circulating clonal expansion of CLA-positive lymphocytes in patients with psoriatic arthritis.
The lack of association between the expression of the CLA molecule in psoriatic skin and synovium may be consistent with existing observations regarding the link between psoriasis and arthritis. For instance, there is no association between the type or distribution of skin involvement and arthritis subgroup [4] . Also a pattern of joint disease typical of mutilating psoriatic arthritis may occur without skin disease or with nail disease only [21] . In the majority of patients, the skin disease presents first and exacerbations of both skin and joint disease are only coincident in 030% of patients [6] . We have included two patients with simultaneous exacerbations of skin and joint disease, one of whom had a higher percentage of CLA-positive lymphocytes than any other synovial sample; however, the intensity of expression was noted to be less than in skin psoriasis. In previous work, one sample of liver was found to have 40% CLA-positive T lymphocytes [15] . Our patient had a severe active synovitis in his knee, suggesting that during acute inflammation general mechanisms might override specific homing mechanisms.
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